L-tert-Leucine methyl ester hydrochloride | CAS:63038-27-7

We serve L-tert-Leucine methyl ester hydrochloride CAS:63038-27-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
L-tert-Leucine methyl ester hydrochloride

Chemical Name:  L-tert-Leucine methyl ester hydrochloride
CAS.NO:63038-27-7
Synonyms:
H-Tle-OMe.HCl
L-Valine, 3-methyl-, methyl ester, hydrochloride (1:1)
Methyl 3-methyl-L-valinate hydrochloride (1:1)

Molecular Formula:C7H16ClNO2
Molecular Weight:181.66000

Physical and Chemical Properties:
Density: /
Boiling point: 206.8ºC at 760 mmHg
Melting point: 183-186 ° C
Flash point: 78.9ºC
Refractive index: 16.5 ° (C=1, MeOH)

Specification:
Appearance:white to off-white powder
Purity:≥98%
Moisture Content: ≤0.5%

Packing:
 25kg  cardboard drum or according to customer specified requirements
Storage:-20°C Freezer.Stored in a cool and dry well-closed container. Keep away from moisture and strong light/heat.
Application:Intermediates of  Atazanavir sulfate  CAS:229975-97-7
Intermediates of  Atazanavir   CAS:198904-31-3



Contact us for information like L-tert-Leucine methyl ester hydrochloride chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Methyl 3-methyl-L-valinate hydrochloride (1:1) physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,L-tert-Leucine methyl ester hydrochloride Use and application,H-Tle-OMe.HCl technical grade,usp/ep/jp grade.


Related News: With the continuous advancement of economic globalization, the division of labor and cooperation around the world has become increasingly apparent. The fine chemical industry has the foundation of global division of labor and cooperation due to its long and complex industrial chain.3-Chloropropyne manufacturer It is delivered to hospitals and pharmacies until it reaches the patient.tert-Butyl 3-oxoazetidine-1-carboxylate supplier Additional results from the trial with data on another goal of extending survival is expected in 2020, AstraZeneca said.-Butylbenzofuran vendor Higher-risk MDS is a disease with significant unmet need, and we are pleased to be able to support healthcare professionals seeking access to rigosertib, ahead of its commercial launch,” said Mark Corbett, EVP, Inceptua Medicines Access.Britons being brought from Wuhan to the UK are being placed in quarantine at Arrowe Park Hospital in the Wirral, northwest England, Raab said.